Evidence map›Paper›PMID 41625072›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Navigating change: the ongoing efforts to contain poliovirus in the United States.

Christy Ottendorfer, Lia Haynes Smith, Shelley Jorgensen

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christy OttendorferU.S. Centers for Disease Control and Prevention, Office of Readiness and Response, Division of Regulatory Science and Compliance, U.S. National Authority for Containment of Poliovirus, Atlanta, GA, United States.
Lia Haynes SmithU.S. Centers for Disease Control and Prevention, Office of Readiness and Response, Division of Regulatory Science and Compliance, U.S. National Authority for Containment of Poliovirus, Atlanta, GA, United States.
Shelley JorgensenU.S. Centers for Disease Control and Prevention, Office of Readiness and Response, Division of Regulatory Science and Compliance, Atlanta, GA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

United States (U.S.) poliovirus research and vaccination programs have eliminated polio in the U.S. and brought the world to the brink of polio eradication. As part of a global action plan, the U.S. committed to safeguard the polio eradication efforts through identification of domestic facilities holding poliovirus materials and implementing stringent laboratory biocontainment measures overseen by U.S. CDC. In January 2025, the White House announced the withdrawal of the U.S. from the WHO. Consistent with the administration's policy and guidance, the U.S. CDC is developing a new framework for poliovirus containment independent of WHO to protect the health security of the U.S. from the continued threat of poliovirus and ensure the long-term success of polio eradication.

Indexed as

biosafetylaboratory biorisk managementpoliovirusUSAWHO

Identifiers

PMID41625072
PMCPMC12852423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.